Senbo Liu

Title: Innovations by Senbo Liu: Contributions to Biotechnology

Introduction

Senbo Liu, an accomplished inventor based in Guangdong, China, has made significant contributions to the field of biotechnology. With a focus on developing antibodies, Liu's work exemplifies the intersection of innovative research and practical applications, particularly in the realm of immunology.

Latest Patents

Senbo Liu holds a patent for the "Development of recombinant chicken IGY SCFV antibody raised against human thymidine kinase 1 expressed in prokaryotic cells and use thereof." This patent discloses the expression of a recombinant chicken IgY scFv antibody, which targets human thymidine kinase 1 (hTK1) when produced in prokaryotic cells. The resulting antibodies are notable for their good immunoreactivity, high specificity and sensitivity, and ease of separation and purification.

Career Highlights

Liu's career is marked by his innovative research and the successful development of his patented technology. His work has positioned him as a key figure in his company, Sino-Swed Tongkang Bio-Tech (Shenzhen) Limited, where he plays an essential role in advancing biotechnological solutions.

Collaborations

Throughout his career, Senbo Liu has collaborated with notable coworkers, including Hu Chen and Zuosheng Li. These partnerships have helped enhance the development and application of biotechnological products, allowing for shared expertise and innovative breakthroughs.

Conclusion

Senbo Liu continues to exemplify the spirit of innovation in biotechnology through his research and patents. His contributions not only advance our understanding of antibody development but also pave the way for new therapeutic applications that could significantly impact healthcare. With a dedicated team and a commitment to science, Liu is poised to make further advancements in this vital field.